mitozolomide has been researched along with Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Citti, L; Colombo, MG; Mariani, L; Piccirilli, A; Poliseno, L; Rainaldi, G | 1 |
| Armand, JP; Delgado, FM; Hayat, M; Herait, P; May-Levin, F; Oliveira, J; Rougier, P | 1 |
| Aamdal, S; Boyd, MR; Fodstad, O; Pihl, A | 1 |
3 other study(ies) available for mitozolomide and Breast Cancer
| Article | Year |
|---|---|
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Nitrogen Mustard Compounds; O(6)-Methylguanine-DNA Methyltransferase; Oligonucleotides; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Nitrogen Mustard Compounds | 1988 |
Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Nitrogen Mustard Compounds; Sarcoma; Transplantation, Heterologous; Tumor Stem Cell Assay | 1985 |